Browsing Barts Cancer Institute by Title
Now showing items 17-36 of 1165
-
A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma
(2014)Improved usage of the repertoires of pancreatic ductal adenocarcinoma (PDAC) profiles is crucially needed to guide the development of predictive and prognostic tools that could inform the selection of treatment options. -
A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma.
(2014)Improved usage of the repertoires of pancreatic ductal adenocarcinoma (PDAC) profiles is crucially needed to guide the development of predictive and prognostic tools that could inform the selection of treatment options. -
Abstract 4576: 3D in vitro models uncover malignant cell intrinsic and extrinsic mechanisms of CAR-T cell resistance in high grade serous ovarian cancer
(American Association for Cancer Research (AACR), 2023-04-04) -
Abstract 5591: Circulating tumor DNA for recurrence prediction and efficacy analysis in the ICONIC trial of peri-operative FLOT and avelumab (PD-L1) in localized esophago-gastric adenocarcinoma
(American Association for Cancer Research (AACR), 2023-04-04) -
Abstract 5593: Clonal mutation burden and evolutionary dynamics analysis in metastatic gastro-esophageal adenocarcinoma (GEA) by error corrected whole-exome circulating tumor DNA sequencing
(American Association for Cancer Research (AACR), 2023-04-04) -
Abstract 958: Effective targeting of pancreatic ductal adenocarcinoma metastases with an integrin αvβ6-targeting peptide-drug conjugate
(American Association for Cancer Research (AACR), 2021-07-01) -
Abstract IA38: Defining lymphoma reservoirs: Clues from the genomics
(American Association for Cancer Research (AACR), 2020-11-01) -
Abstract P6-10-05: Mutations in the RNA Splicing Factor SF3B1 drive endocrine therapy resistance and confer a targetable replication stress response defect through PARP inhibition
(American Association for Cancer Research (AACR), 2023-03-01) -
Adaptive immunity in cancer immunology and therapeutics.
(2014)The vast genetic alterations characteristic of tumours produce a number of tumour antigens that enable the immune system to differentiate tumour cells from normal cells. Counter to this, tumour cells have developed mechanisms ...